Christopher Slapak

Christopher Slapak

Inga fler pågående positioner
67 år
Health Technology
Consumer Services
Health Services

Profil

Christopher Slapak worked as Vice President-Early Phase Development Oncology at Eli Lilly & Co. from 1996 to 2017.
He also worked as an Assistant Professor at Dana-Farber Cancer Institute, Inc. and as an Associate Professor-Clinical at The Indiana University School of Medicine.
In 2018, he became the Chief Medical Officer at Prelude Therapeutics, Inc. and in 2020, he became the Chief Medical Officer at Vor Biopharma, Inc. Dr. Slapak received his undergraduate degree from The Ohio State University and his doctorate degree from Pritzker School of Medicine.

Tidigare kända positioner av Christopher Slapak

FöretagPositionSlut
VOR BIOPHARMA INC. Teknisk/Vetenskaplig/F&U Direktör 2022-05-06
PRELUDE THERAPEUTICS INCORPORATED Teknisk/Vetenskaplig/F&U Direktör 2019-06-01
ELI LILLY AND COMPANY Företagsledare/Principal 2017-12-01
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Christopher Slapaks erfarenhet

Christopher Slapaks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

81

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Christopher Slapak
-40% : Prolongation exceptionnelle ➤➤➤➤
d
:
:
TA FÖRDEL AV DET NU